Please assess the completion status of the following clinical trial:

Trial Title: Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* term (≥ 37+0 weeks) singleton pregnancy~* a vertex presentation~* ruptured membranes for less than 12 hours~* negative Group B Streptococcus (GBS) culture performed between 35 and 37 weeks~Exclusion Criteria:~* active labor~* absence of GBS culture or indication for GBS antibiotic prophylaxis (such as maternal GBS colonization between 35 and 37 weeks, GBS bacteriuria, prior infant with GBS sepsis)~* contraindication to expectant management (such as fetal distress, meconium staining of the amniotic fluid or chorioamnionitis) or to vaginal delivery

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Antibiotic group (Type: ACTIVE_COMPARATOR): women submitted to antibiotic prophylaxis
- Control group (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).